GSK Looking For Under-Appreciated M&A Targets, Not Trying To Be Next Roche Or AstraZeneca – GSK (NYSE:GSK)
[ad_1] GSK plc GSK chief commercial officer Luke Miels says the company is looking at M&A targets that are under-appreciated worth $1 billion-$2.5 billion and avoid getting into a ‘bidding…
10 Communication Services Stocks Moving In Friday’s Pre-Market Session – Leafly Holdings (NASDAQ:LFLY), SPAR Group (NASDAQ:SGRP), National CineMedia (NASDAQ:NCMI), So-Young Intl (NASDAQ:SY), Grom Social Enterprises (NASDAQ:GROM), iQIYI (NASDAQ:IQ), 9F (NASDAQ:JFU), iClick Interactive Asia (NASDAQ:ICLK), Zhihu (NYSE:ZH), Fangdd Network Group (NASDAQ:DUO)
[ad_1] Gainers National CineMedia NCMI shares increased by 13.5% to $0.27 during Friday’s pre-market session. The company’s market cap stands at $22.1 million. So-Young Intl SY stock increased by 6.29%…
NaaS Technology Appoints Alex Wu As Finance Chief – Naas Technology (NASDAQ:NAAS)
[ad_1] NaaS Technology Inc NAAS has appointed Alex Wu as its Chief Financial Officer, effective January 15, 2023. Wu has also been appointed the President of the company and will…
New Oral COVID-19 Antiviral Might Be Better Than Pfizer’s Paxlovid With Faster Recovery, Fewer Side Effects, Data Shows – Pfizer (NYSE:PFE)
[ad_1] by Vandana Singh, Benzinga Editor December 30, 2022 7:39 AM | 1 min read A study in China shows that a remdesivir analog, dubbed VV116, is as effective…
Why Dermata Therapeutics Shares Are Trading Higher By Over 100%; Here Are 21 Stocks Moving Premarket – Argo Blockchain (NASDAQ:ARBK), Waitr Hldgs (NASDAQ:ASAP)
[ad_1] Gainers Dermata Therapeutics, Inc. DRMA shares rose 105% to $0.41 in pre-market trading after the company requested to withdraw its registration on Form S-1 and said it does…